Biosynex SA
PAR:ALBIO

Watchlist Manager
Biosynex SA Logo
Biosynex SA
PAR:ALBIO
Watchlist
Price: 1.18 EUR -0.42% Market Closed
Market Cap: 22.1m EUR

Wall Street
Price Targets

ALBIO Price Targets Summary
Biosynex SA

There are no price targets for ALBIO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Biosynex SA Competitors:
Price Targets
DXR
Daxor Corp
121% Upside
853
Microport Scientific Corp
14% Downside
2291
Lepu Scientech Medical Technology Shanghai Co Ltd
15% Upside
CEVI
CellaVision AB
32% Upside
ZBH
Zimmer Biomet Holdings Inc
6% Upside
BDX
Becton Dickinson and Co
14% Upside
DCTH
Delcath Systems Inc
142% Upside
STIM
Neuronetics Inc
96% Upside

Revenue
Forecast

Revenue Estimate
Biosynex SA

For the last 13 years the compound annual growth rate for Biosynex SA's revenue is 42%. The projected CAGR for the next 1 year is 45%.

42%
Past Growth
45%
Estimated Growth
Estimates Accuracy
-21%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biosynex SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Biosynex SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-65%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALBIO's stock price target?
Not Available

ALBIO doesn't have any price targets made by Wall Street professionals.

What is Biosynex SA's Revenue forecast?
Projected CAGR
45%

For the last 13 years the compound annual growth rate for Biosynex SA's revenue is 42%. The projected CAGR for the next 1 year is 45%.

Back to Top